 0 Table of Contents |
  1 Home |
  2 Artifacts Summary |
   2.1 Search by IPTp ANC Number Hash |
   2.2 IPTp Adverse Drug Reaction Observation |
   2.3 IPTp ANC Provider |
   2.4 IPTp Care Plan |
   2.5 IPTp CHP Follow-Up Task |
   2.6 IPTp Dose Administration |
   2.7 IPTp Eligibility Flag |
   2.8 IPTp Enrolled Patient |
   2.9 IPTp Enrollment Episode |
   2.10 IPTp Gestational Age Observation |
   2.11 IPTp Health Facility |
   2.12 IPTp Issue Report |
   2.13 IPTp Planned Dose Schedule |
   2.14 IPTp Practitioner Role |
   2.15 IPTp Pregnancy Condition |
   2.16 IPTp Prior Dose History Observation |
   2.17 IPTp Program Feedback Observation |
   2.18 IPTp SMS Communication |
   2.19 IPTp SMS Consent |
   2.20 IPTp SP Medication |
   2.21 IPTp Administration Method |
   2.22 IPTp ANC Number Hash |
   2.23 IPTp CHP Follow-up Flag |
   2.24 IPTp Dose Confirmation Status |
   2.25 IPTp Dose Number |
   2.26 IPTp Dose Spacing Valid Flag |
   2.27 IPTp Gestational Age Band |
   2.28 IPTp Issue Resolution Status |
   2.29 IPTp Language Preference |
   2.30 IPTp Manual Review Flag |
   2.31 IPTp Messaging Status |
   2.32 IPTp Pregnancy Outcome |
   2.33 IPTp Provider MSISDN |
   2.34 IPTp Reminder Anchor |
   2.35 IPTp SMS Consent |
   2.36 IPTp Administration Method Value Set |
   2.37 IPTp ADR Severity Value Set |
   2.38 IPTp Dose Confirmation Status Value Set |
   2.39 IPTp Gestational Age Band Value Set |
   2.40 IPTp Issue Type Value Set |
   2.41 IPTp Language Preference Value Set |
   2.42 IPTp Messaging Status Value Set |
   2.43 IPTp Pregnancy Outcome Value Set |
   2.44 IPTp Reminder Type Value Set |
   2.45 IPTp Resolution Status Value Set |
   2.46 IPTp SMS Message Category Value Set |
   2.47 IPTp-SP Code System |
   2.48 24h Nudge (EN) |
   2.49 24h Nudge (SW) |
   2.50 72h Nudge (EN) |
   2.51 72h Nudge (SW) |
   2.52 Confirmation Ack: Not Yet (EN) |
   2.53 Confirmation Ack: Not Yet (SW) |
   2.54 Confirmation Ack: Took It (EN) |
   2.55 Confirmation Ack: Took It (SW) |
   2.56 Example Active Pregnancy |
   2.57 Example CHP Follow-Up Task |
   2.58 Example Eligibility Flag |
   2.59 Example Feedback - Reminders Did Not Help |
   2.60 Example Feedback - Reminders Helped |
   2.61 Example Gestational Age Observation |
   2.62 Example IPTp ANC Provider |
   2.63 Example IPTp Care Plan |
   2.64 Example IPTp Dose 1 Administration (DOT) |
   2.65 Example IPTp Dose 2 Administration (Self-Admin, Confirmed) |
   2.66 Example IPTp Enrolled Patient |
   2.67 Example IPTp Enrollment Episode |
   2.68 Example IPTp Health Facility |
   2.69 Example Lost Medicine Issue Report |
   2.70 Example Mild ADR |
   2.71 Example Other (Free-Text) Issue Report |
   2.72 Example Planned Dose 3 |
   2.73 Example Pregnancy Condition - Delivery Outcome |
   2.74 Example Prior Dose History Observation |
   2.75 Example Provider-Facility Binding |
   2.76 Example Severe ADR |
   2.77 Example SMS Consent |
   2.78 Example SP Medication |
   2.79 Example T-0 SMS Reminder |
   2.80 Feedback Ack: No (EN) |
   2.81 Feedback Ack: No (SW) |
   2.82 Feedback Ack: Yes (EN) |
   2.83 Feedback Ack: Yes (SW) |
   2.84 Feedback Prompt (EN) |
   2.85 Feedback Prompt (SW) |
   2.86 InfoAFYA #1: Trust (EN) |
   2.87 InfoAFYA #1: Trust (SW) |
   2.88 InfoAFYA #2: Autonomy Transition (EN) |
   2.89 InfoAFYA #2: Autonomy Transition (SW) |
   2.90 InfoAFYA #3: Norm Reinforcement (EN) |
   2.91 InfoAFYA #3: Norm Reinforcement (SW) |
   2.92 InfoAFYA #4: Identity Reinforcement (EN) |
   2.93 InfoAFYA #4: Identity Reinforcement (SW) |
   2.94 InfoAFYA #5: Side-Effect Reassurance (EN) |
   2.95 InfoAFYA #5: Side-Effect Reassurance (SW) |
   2.96 InfoAFYA #6: Completion Mindset (EN) |
   2.97 InfoAFYA #6: Completion Mindset (SW) |
   2.98 InfoAFYA #7: ANC Continuity (EN) |
   2.99 InfoAFYA #7: ANC Continuity (SW) |
   2.100 Issue Flow Step 1: Problem Type (EN) |
   2.101 Issue Flow Step 1: Problem Type (SW) |
   2.102 Issue Flow: Lost Medicine Response (EN) |
   2.103 Issue Flow: Lost Medicine Response (SW) |
   2.104 Issue Flow: Mild Side Effect Response (EN) |
   2.105 Issue Flow: Mild Side Effect Response (SW) |
   2.106 Issue Flow: Other - Auto-Reply (EN) |
   2.107 Issue Flow: Other - Auto-Reply (SW) |
   2.108 Issue Flow: Other - Free Text Prompt (EN) |
   2.109 Issue Flow: Other - Free Text Prompt (SW) |
   2.110 Issue Flow: Severe Side Effect Response (EN) |
   2.111 Issue Flow: Severe Side Effect Response (SW) |
   2.112 Issue Flow: Side Effect Severity Prompt (EN) |
   2.113 Issue Flow: Side Effect Severity Prompt (SW) |
   2.114 Onboarding Message 1 (EN) - Enrollment Confirmation |
   2.115 Onboarding Message 1 (SW) - Enrollment Confirmation |
   2.116 Onboarding Message 2 (EN) - How It Works |
   2.117 Onboarding Message 2 (SW) - How It Works |
   2.118 Onboarding Message 3 (EN) - How to Take SP |
   2.119 Onboarding Message 3 (SW) - How to Take SP |
   2.120 Onboarding Message 4 (EN) - Safety + InfoAFYA Bridge |
   2.121 Onboarding Message 4 (SW) - Safety + InfoAFYA Bridge |
   2.122 STOP Acknowledgement (EN) |
   2.123 STOP Acknowledgement (SW) |
   2.124 T-0 Reminder (SW) |
   2.125 T-3 Reminder (EN) |
   2.126 T-3 Reminder (SW) |